Ricardo Otazo, PhD, MSc, BSc

Chief of Magnetic Resonance Imaging and Spectroscopy Physics; Vice Chair, Research.

Ricardo Otazo, PhD, MSc, BSc

Chief of Magnetic Resonance Imaging and Spectroscopy Physics; Vice Chair, Research.
Ricardo Otazo

Office Phone



BsC, Electrical Engineering, Universidad Católica, Paraguay; PhD, Engineering, University of New Mexico

I am responsible for the MRI and spectroscopy physics program. This includes the development and translation of new techniques, protocol optimization, quality analysis, and collaborations with the Departments of Radiology and Radiation Oncology.

My research is focused on the development of rapid, motion-robust, and quantitative MRI methods using mathematical, physical, and computational models. One highlight is working on compressed sensing-based techniques, which can reduce examination times. We want to be able to do imaging procedures while people are breathing normally that also increase the amount of information in an image by adding new physiological dimensions. I actively collaborate with industry leaders to translate these methods into clinical practice.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Ricardo Otazo discloses the following relationships and financial interests:

  • NYU Langone Health
    Intellectual Property Rights

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures